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Studies of the expression patterns of many genes simulta-
neously lead to the observation that even in closely related
pathologies, there are numerous genes that are differentially
expressed in consistent patterns correlated to each sample
type. The early uses of the enabling technology, microarrays,
was focused on gathering mechanistic biological insights.
The early findings now pose another clear challenge, finding
ways to effectively use this kind of information to develop
diagnostics.
1. Introduction
The profiling of transcription patterns is a central
and long-standing tool in molecular biology. Recently,
it has become possible to gather this kind of data for
many genes simultaneously, allowing a wider view of
the transcriptional activity of a particular cell type or
tissue [1,2]. The fundamental assumption concerning
the utility of such transcript abundance profiles is that
transcription profiles convey information about the pro-
cesses operating in a cell of a given type or state. The
view obtained is limited to those parts of operations
directly influencing the transcriptional activity of the
cell. Still, it is obvious that even a clear and complete
listing of the variances in transcription between the op-
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erations of a healthy cell and those of a diseased cell
of the same type would provide useful information. At
a minimum, those differences that are most extreme
could provide useful markers to differentiate the dis-
eased cells from the healthy ones in routine diagnos-
tic testing. In some cases, this information could con-
ceivably be much more useful. In the field of oncol-
ogy, our particular area of interest, the variances might
point to some difference that could be exploited to kill
or terminally differentiate the cancerous cells through
some form of treatment. These tantalizing possibilities
have led many researchers to pursue the development of
methods for gathering and analyzing expression data.
The experiences gained through these early efforts
have begun to outline useful approaches to the collect-
ing and analyzing expression profile data and to identify
the most serious obstacles to realizing the desired ben-
efits. This review will summarize some of the strengths
of data viewing and analysis approaches used to date,
and sketch some of the approaches and limitations to
the development of more powerful forms of analysis.
2. Methods of analysis
2.1. Clustering/correlation
As might be expected, the first attempts to harness the
information provided in profiles centered on the most
readily detected forms of relationships in these kinds
of observations, simple correlation of similarities [3].
The typical way to view similarities is to perform a
clustering operation. This type of comparison is meant
as a very preliminary way to look at data, a way of
discovering trends. The methods do not offer any esti-
mate of the way in which the variance arising from the
system biology or the measurement procedure will af-
fect the reproducibility of the resulting groupings. Ad-
ditionally, the similarity measurement steps used fre-
quently incorporate averaging and normalization steps
that make it impossible to compare the resulting sets
of similarity measurements in a quantitative fashion.
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In spite of these drawbacks, the use of correlation and
clustering has a rich history in mathematics and engi-
neering, and a large and growing number of the extant
approaches to clustering data are being examined in the
context of expression profile analysis. They provide a
very quick way to see the most evident relationships,
and when supplemented with other forms of analysis
or connections to prior knowledge can help identify
differences in expression worth further consideration.
2.2. Gene by gene correlation
At the start of efforts to gather transcription profiles,
there were two simple expectations for clustering re-
sults, both based on historical knowledge of transcrip-
tional regulation. The first was that genes responding
to a given type of signal, such as a fundamental change
in metabolism, would be identifiable in data from a
sample series that spanned such a transition, due to the
similarity of their transcriptional response to the signal.
This was quickly demonstrated in yeast undergoing a
diauxic shift [4]. Many subsequent experiments in a
variety of systems have demonstrated that correlating
similarities of response can be a very powerful way of
grouping genes involved in processes such as serum
response [5], or cell cycling [6,7]. Very complex data
sets containing mixtures of developmental time-course
and mutant analysis series have been shown to allow
clustering along functional lines [8].
A further power of this form of correlation is its
power to group genes whose expression is driven by
the same kinds of cis-regulatory sites. Demonstrations
of the clustering of genes sharing known or new cis-
regulatory sites have been presented in several studies
of transcription dynamics associated with the yeast cell
cycle [6,9]. While these results provide a demonstra-
tion of the competence of clustering to disclose explicit
co-regulation, both these studies, and one examining
transcription during meiosis [10] suggest cautious ex-
pectations for the extent of utility of clustering in dis-
closing cis-regulatory sharing. Even in yeast, it ap-
pears to be difficult to identify a large fraction of the
motifs that must be in place. Clustering paired with
promoter sequence searching is most useful for those
elements that have the least ambiguity and the greatest
length. This signal to noise constraint makes the cluster
and search strategy likely to be most useful in identi-
fying genes sharing already discovered cis-regulatory
elements in multi-cellular organisms. This is due to
their large genome size, their typically short and vari-
able cis-regulatory sequences and their highly combi-
natorial use of these regulators (extensively reviewed
by Davidson in [11]).
The results of a number of systematic informatics
efforts can also be expected to enhance the kinds of
insight that correlation can provide. Various efforts to
associate the currently available knowledge of genes’
functions and relationships with other genes are under
development. One approach that has already reached
a fairly high level of sophistication is the production
of gene ontologies [12]. This is a large, collaborative
effort that seeks to provide curated information about
the biological role of genes in many different organ-
isms using a unitary set of classifiers (controlled vo-
cabulary). As the human gene ontology becomes more
complete, it can be used to provide a summary view
of the various biological activities represented in a par-
ticular cluster. Known genes in other species could
supplement this process by suggesting that a human
EST of unknown function that is related by sequence to
the known gene may have a function that makes sense
in the context of the cluster in which it falls. Simi-
lar aid in deciphering function may become available
from a less supervised, indexing approach to evaluating
gene functions. One example of this type of approach
is the High-density Array Pattern Interpreter program
(http://array.ucsd.edu/tools.htm). This program uses
controlled terminology hierarchies, based on the Na-
tional Library of Medicine’s Medical Subject Head-
ings, to delineate how genes have been described in the
published literature. In general, any further character-
ization that can be associated with a gene is likely to
improve the odds of estimating whether a gene with
a biologically interesting expression pattern should be
further studied as a candidate marker or target.
2.3. Sample by sample correlation
The second a priori expectation for expression pat-
terns was that it would be possible to discern differing
types of healthy and pathological cells by considering
the overall profile of similarities and differences across
many genes. There have been many demonstrations of
the use of overall transcription similarity measures to
group samples into their previously known classes [13–
15]. There have also been demonstrations of the prac-
ticality of using this strategy to discover classes within
samples that could not be subdivided in this fashion
by conventional measurements [16–18]. Surveying the
uses of this strategy, it has become apparent that there
are both differing biological bases driving the separa-
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tions and a wide spectrum in the number of genes that
strongly contribute to the separation.
One clear component of the separation between cell
types, a “tissue of origin” component arises from the
particular differentiation state of the cells being stud-
ied. It is easy to imagine that vastly different cell types,
such as muscle versus neuron, would show consider-
able differences in their expression of specialized gene
products and be readily classified based on those differ-
ences. It was less easy to predict that even lymphomas
arising from close relatives in the B-cell lineage have
a large number of transcriptional differences that can
be easily exploited for classification [16]. Some other
ways in which surprising degrees of variation have been
seen are evident in a study of tumor material from breast
cancer [17]. A very clear finding of this study was the
distinctiveness of individual tumors. Primary tumors
and their metastases were found to have the highest
degree of similarity in this study, which encompassed
a variety of breast tumor types. That a tumor growing
at a distant site and time than its primary is much more
similar to its primary than to another metastasis aris-
ing from the same type of tissue implies that there is
a large “space” of transcriptional settings available to
a developing tumor. It also implies that the “position”
the tumor occupies in that space is well separated from
that chosen by other tumors of similar origin.
As the volume of expression space inhabited by cells
of different types does have a significant impact on
the ease, resolution and reliability of discrimination
between diseases that can be achieved via expression
profiling, it is worth having a look at the amount and
magnitude of variance there is between samples. It is
difficult to get a feel for this from the processed data
usually presented in papers, since the most common
representation is the use of a color scale, which tends
to understate the differences. A much different intu-
ition is conveyed by a scatter plot comparing the av-
erage intensities of the two fluorescent cDNA probes
hybridized at each immobilized detector on a cDNA
array. Three such plots are presented in Fig. 1. Panels
A and B show that when an mRNA pool derived from
either a melanoma cell line or a myeloid cell line is
profiled against itself, there is very little variance in the
intensity of any of the genes detected. Panel C shows
the contrasting result of widespread variation, ranging
from minor to major differences, when these different
mRNA pools are compared to each other. This is not an
exceptional result; it is the typical outcome. It appears
that every cell state has unique settings for the expres-
sion levels of most of the genes expressed in the cell,
including both the ubiquitously expressed genes and
the genes specific to particular states. This level of id-
iosyncracy of expression differences provides both vast
opportunities and complications to the identification of
useful disease markers. The likelihood of finding a
small set of accurate, discriminative markers that could
be pressed into service in a traditional format such as
immunohistochemistry increases with the number of
differentially expressed genes available, however one
must be ready to sift many candidates for consistency
and tolerance to noise.
2.4. Simple gene ranking methods
When looking at the numerous correlates between
genes and samples that result from a large array study
one is frequently overwhelmed by the many possibly
interesting genes that would make sense to study, based
on the relevance of their known biological activities to
the system being explored. To further reduce the num-
ber of candidates, one can choose a variety of filters
based on the pattern of gene expression in the various
sample types. Two simple tools have been described
for carrying out such analysis. One, the “Weighted-
List” method, is based on estimating the compactness
within sample groups and the separation between sam-
ple groups that a given gene or genes’ expression val-
ues would produce between the sample types [15,18].
This approach is conceptually related to the standard
statistical F and t-tests. A geometric interpretation of
the weight value produced by this analysis is presented
in Fig. 2. The other method, Threshold Number of
Misclassification (TNoM), is based on finding the min-
imal error rate of separation for ranked samples. The
samples are ranked according to the expression val-
ues a gene produces, and then separated at a point that
produces the least misclassifications [18–20].
Both of these methods are based on the supposition
that those genes whose action is of strong consequence
to the biological differences between the samples will
accurately separate them. The Weighted List method
emphasizes the average extent to which expression val-
ues separate the samples, making it a useful tool for
finding genes with relatively large shifts in expression
between sample types. The TNoM method empha-
sizes the integrity of the separation, making it useful
for finding genes that accurately separate the samples
but do not have as large ratio shifts. Genes that produce
particularly clear discriminations achieve high scores
with both measurements. Both methods of analysis
are tested by forming permuted sample groups of the
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Fig. 1. Scatter-plots of average channel intensity per gene. The average red (y-axis) and green (x-axis) intensities at each immobilized gene
detector element on an array of approximately 7000 genes is plotted. A) RNA from cell line ML1 used for both channels. B) RNA from cell line
UACC903 used for both channels. C) RNA from UACC 903 used for red channel, RNA from cell line ML1 used for green channel. (From [22]).
same size as the authentic sample sets, but with ran-
domized membership. Running and scoring a thousand
such permuted sets provides an empirical estimate of
the highest expected weight or TNoM value in a ran-
dom collection of biological samples, providing a use-
ful estimate of the lower limit on values that are sig-
nificant. Figure 3 is a diagram showing this kind of
analysis applied to a fairly homogeneous subset of 19
melanomas versus 12 melanomas having much greater
diversity in their expression profiles [17]. The black
line depicts the actual number of genes able to sepa-
rate the samples with the indicated level of accuracy
(on the x-axis). The gray line depicts the expected
number of such separating genes when 19 samples are
chosen uniformly at random and designated as a class.
The error bars indicate the 95% confidence interval
for these numbers, under the same stochastic model.
The difference between the authentic sample curve and
the permuted sample/theoretical curve shows that there
are many genes whose expression pattern aligns with
the sample sets in a very non-random way. A simi-
lar differential is seen with the Weighted List results.
Sharp overabundance of informative or highly separat-
ing genes is also observed in other studies such as [14–
16].
Other approaches to finding highly discriminative
genes include ones where methods similar or identi-
cal to those used in formal statistical sample classi-
fication are explored. Examples include studies of
differences in gene expression between acute myeloid
leukemia (AML) and acute lymphoblastic leukemia
(ALL) [14], and between breast tumors arising in pa-
tients with or without the breast cancer predisposing
mutations BRCA1 or BRCA2. The methods utilized
in these studies explored the results of allowing larger
numbers of genes to participate to varying extents in a
decision about what class a given sample was in. Such
studies provide another way of probing the robustness
of the differentiation in expression patterns. An esti-
mate of the consistency and robustness of the differ-
entiation is achieved by serially building the decision
function using all of the samples save one, for all of
the N-1 sample sets, a process known as leave-one-out-
cross-validation. The results may be further queried
to determine whether a significant fraction of identical
deciding genes are employed in all sets and whether
the classification is approximately equally accurate in
all cases. Forming permuted sample groups with ran-
domized membership and reconstituting and re-scoring
a classifier, as above, allows estimation of the signifi-
cance of the achieved classification.
These and many other approaches to finding dis-
criminating genes for further study in mechanistic or
diagnostic settings are in the early phases of develop-
ment. A more refined sense of their practical utility
will emerge as experimental determination of the im-
portance of the high scoring genes to the phenotypic
differences between the sample sets is carried out.
2.5. Classification
The ability to employ microarray methodology to
carry out formal diagnostic classification of tissue is
a reasonable long-term goal, given the demonstrated
ability of the method to discern differences in the pat-
terns of gene expression between normal and healthy
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Fig. 2. Weighted Discriminator Method. Assuming K categories (or clusters) for a set of samples, a discriminative weight for each gene can
be evaluated by w = Average(BD) / (Average(WD) + a) where Average(BD) is the average of the between cluster Euclidean distance for all
pairs of clusters (total of (K*K-1)/2 pairs), and Average(WD) is the weighted average of the within-cluster distance (weighted by the number of
samples in the cluster). The within-cluster distance is the average distance of all pairs of samples in the cluster. a is a small constant to prevent
zero denominator case. (See http://www.nhgri.nih.gov/DIR/Microarray/discriminative.html).
tissue, and between differing types of diseased tissue.
At the present there appear to be two main obstacles to
making profiling a sufficiently practical form of diag-
nostic to find wide use. The first difficulty is an ana-
lytical one. How can very good candidate diagnostic
panels be rapidly developed from profile data? The
ideal panel would be one that used a very small number
of genes, each of which provided at least some unique
information (i.e. information that was not equivalent
to the contribution of the other genes) and which was
relatively insensitive to the levels of biological variance
and measurement noise routinely encountered.
The problems associated with finding small classi-
fier gene sets that meet robustness and uniqueness cri-
teria, using expression-profiling data, have been con-
cisely reviewed by Dougherty [21]. The general ba-
sis of the problem is that expression studies tend to be
carried out as surveys aimed at developing insight into
the biological mechanics of pathology. In studies of
human tissue the goal has been to sample the broad-
est number of genes possible with the limited number
of tissue samples and microarrays available. A con-
sequence of this strategy has been that in most cases,
there are neither sufficient numbers of samples nor suf-
ficient numbers of replications of data sets to get good
estimates of the error rates over the general population
of the various genes in classification. Given small sam-
ple sets and large numbers of genes being sampled, it
becomes possible to identify many small sets of genes
for which the estimated error of classification is zero.
In many cases, this estimate will not be markedly im-
proved by small-sample-numbervalidation procedures,
such as leave-one-out cross-validation. As was men-
tioned in the Gene Ranking section above, there are
64 Y. Chen et al. / Analysis of expression patterns: The scope of the problem, the problem of scope
Fig. 3. Threshold Number of Misclassifications data from melanoma study [18]. The black line shows the number of genes in the original data set
capable of producing the given number of misclassifications. The gray line is the result if the samples in the sets containing 19 and 12 members
are permuted. Error bars show the calculated 95% confidence interval for the same size data set if gene expression behavior is independent and
random relative to the samples.
many genes whose differences in expression pattern are
aligned with differences in sample type in a very simple
way, being more highly expressed in one sample type
than the other. This produces a considerable overlap
of the information content in relation to sample type
in these sets of genes with the attendant problem that
combining these genes in a classifier can easily lead to
decreased performance via increased noise. An urgent
need is therefore some readily computable analysis of
the data that will help identify the most noise-resistant
and least redundant classifier gene sets.
In addition to the problems of designing a classifier
and choosing the genes that will provide the highest
accuracy in the classifier, there are pragmatic problems
that further complicate the use of expression profiling
as a diagnostic. The primary analyte in the technique is
mRNA, which is much less stable than DNA or protein,
placing considerable constraints on sample collection.
The methods of converting the mRNA into a species
that can be detected and scored is very sensitive to the
integrity of the mRNA and to contaminants that co-
purify with the mRNA during sample preparation. The
technique, as now practiced, requires significantly more
cells than many diagnostics, and could be confounded
by the presence or variable content of cells other than
disease cells in the sample. Were the technology to be
used in diagnosis, its focus would need to be shifted
from breadth of examination toward precision. The
starting point for practical diagnosis would be a small,
specialized set of genes, not as many genes as possi-
ble, with sufficient replicates of this set to provide the
required degree of measurement precision.
3. Conclusion
Expression profiles can be seen to provide a rich
source of data on the differential expression of genes
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between cell states. Early results have demonstrated
that it is possible to find many genes that exhibit state-
dependent patterns of expression, even between closely
related pathologies. The expression studies carried out
to date have been of sufficiently limited scope to pro-
vide the large amounts of data needed for confident
design of classifiers based on expression data, how-
ever even with limited data the trends are encouraging.
Technologic improvements will continue to increase
the precision and reproducibility of measurement that
can be achieved. Larger studies designed to support the
development of disease markers will no doubt be un-
dertaken. In the shorter term, a good analytic method
for identifying robust candidate classifier gene panels
based on smaller sample number could be developed.
With such a tool, it may be possible to use limited
information to construct immunohistochemical assays,
usable within the sphere of current diagnostic practice.
References
[1] M. Schena, D. Shalon, R.W. Davis and P.O. Brown, Quan-
titative monitoring of gene expression patterns with a com-
plementary DNA microarray, Science 270(5235) (1995), 467–
470.
[2] D.J. Lockhart, H. Dong AND M.C. Byrne et al., Expression
monitoring by hybridization to high-density oligonucleotide
arrays, Nat Biotechnol 14(13) (1996), 1675–1680.
[3] M.B. Eisen, P.T. Spellman, P.O. Brown and D. Botstein, Clus-
ter analysis and display of genome-wide expression patterns,
Proc Natl Acad Sci USA 95(25) (1998), 14863–14868.
[4] J.L. DeRisi, V.R. Iyer and P.O. Brown, Exploring the metabolic
and genetic control of gene expression on a genomic scale,
Science 278(5338) (1997), 680–686.
[5] V.R. Iyer, M.B. Eisen and D.T. Ross et al., The transcriptional
program in the response of human fibroblasts to serum, Science
283(5398) (1999), 83–87.
[6] P.T. Spellman, G. Sherlock and M.Q. Zhang et al., Compre-
hensive identification of cell cycle-regulated genes of the yeast
Saccharomyces cerevisiae by microarray hybridization, Mol
Biol Cell 9(12) (1998), 3273–3297.
[7] P. Tamayo, D. Slonim and J. Mesirov et al., Interpreting pat-
terns of gene expression with self-organizing maps: methods
and application to hematopoietic differentiation, Proc Natl
Acad Sci USA 96(6) (1999), 2907–2912.
[8] A. Ben-Dor, R. Shamir and Z. Yakhini, Clustering gene ex-
pression patterns, J Comput Biol 6(3–4) (1999), 281–297.
[9] S. Tavazoie, J.D. Hughes, M.J. Campbell, R.J. Cho and G.M.
Church, Systematic determination of genetic network archi-
tecture, Nat Genet 22(3) (1999), 281–285.
[10] M. Primig, R.M. Williams and E.A. Winzeler et al., The core
meiotic transcriptome in budding yeasts, Nat Genet 26(4)
(2000), 415–423.
[11] E.H. Davidson, Genomic Regulatory Systems in Development
and Evolution, Academic Press, London, 2001.
[12] M. Ashburner, C.A. Ball and J.A. Blake et al., Gene ontol-
ogy: tool for the unification of biology. The Gene Ontology
Consortium, Nat Genet 25(1) (2000), 25–29.
[13] J. Khan, R. Simon and M. Bittner et al., Gene expression pro-
filing of alveolar rhabdomyosarcoma with cDNA microarrays,
Cancer Res 58(22) (1998), 5009–5013.
[14] T.R. Golub, D.K. Slonim and P. Tamayo et al., Molecular
classification of cancer: class discovery and class prediction
by gene expression monitoring, Science 286(5439) (1999),
531–537.
[15] I. Hedenfalk, D. Duggan and Y. Chen et al., Gene-expression
profiles in hereditary breast cancer, N Engl J Med 344(8)
(2001), 539–548.
[16] A.A. Alizadeh, M.B. Eisen and R.E. Davis et al., Distinct types
of diffuse large B-cell lymphoma identified by gene expression
profiling, Nature 403(6769) (2000), 503–511.
[17] C.M. Perou, T. Sorlie and M.B. Eisen et al., Molecular portraits
of human breast tumours, Nature 406(6797) (2000), 747–752.
[18] M. Bittner, P. Meltzer and Y. Chen et al., Molecular classifi-
cation of cutaneous malignant melanoma by gene expression
profiling, Nature 406(6795) (2000), 536–540.
[19] A. Ben-Dor, L. Bruhn and N. Friedman et al., Tissue classi-
fication with gene expression profiles, J Comput Biol 7(3–4)
(2000), 559–583.
[20] A. Ben-Dor, N. Friedman and Z. Yakhini, Scoring genes for
relevance, Palo Alto, Agilent Technologies, 1999.
[21] E.R. Dougherty, Small sample issues for microarray-based
classification, Comp Funct Genom 2 (2001), 28–34.
[22] Y. Jiang, J. Lueders, A. Glatfelter, C. Gooden and M. Bittner,
in: Profiling human gene expression with cDNA microarrays.
Current Protocols in Human Genetics, N. Dracopoli, ed., John
Wiley & Sons, New York, 2000.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
